Historically, problem opioid users, mainly injectors, have always represented the largest client group receiving specialised drug treatment in the European Union. The needs of large cohorts that started heroin injecting during the heroin ‘epidemics’ of 1980s and 90s have shaped and characterised current European specialist and low-threshold treatment systems. Opioid substitution treatment (OST) is one example of this. With nearly 700 000 Europeans receiving this treatment, OST clients currently represent a substantial proportion of the European treatment population.
This poster was created for the Lisbon Addictions Conference 2015.